deoxycytidine and Lupus Erythematosus, Cutaneous, Subacute

deoxycytidine has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Cohen, PR1
Asada, H; Miyagawa, F; Sho, M; Sugano, Y1
Choi, JN; Subtil, A; Wiznia, LE1
Callen, JP1
Chou, CY; Hsieh, CI; Ko, JH; Wang, KH1
Chiche, L; Dicostanzo, MP; Fongue, J; Harlé, JR; Lardet, D; Meunier, B; Richard, MA; Rouby, F; Terrier, JP1
Ben Shem, E; Ben Zvi, M; Levy, T; Menczer, J; Peled, O; Schreiber, L; Vaknine, H1
Aberer, E; Gerger, A; Kränke, B; Salmhofer, W; Weger, W1
Elenitsas, R; Fernandes, NF; Kist, JM; Rosenbach, M1
Casado-Jiménez, M; Feito-Rodriguez, M; Feltes, RA; Floristan, U; Ramírez-Marín, P; Sendagorta, E; Vidaurrázaga, C1
Guillen, C; Kindem, S; Llombart, B; Requena, C; Ruiz, A; San Martin, O; Traves, V1
Coras, B; Hafner, C; Landthaler, M; Reichle, A; Vogt, T1

Reviews

1 review(s) available for deoxycytidine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
    JAMA dermatology, 2013, Volume: 149, Issue:9

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Deoxycytidine; Drug Eruptions; Female; Gemcitabine; Humans; Lupus Erythematosus, Cutaneous

2013

Other Studies

11 other study(ies) available for deoxycytidine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Chronic cutaneous lupus erythematosus induced by 5-fluorouracil.
    Expert review of clinical pharmacology, 2020, Volume: 13, Issue:8

    Topics: Deoxycytidine; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous

2020
TS-1 (tegafur/gimeracil/oteracil)-induced systemic lupus erythematosus with skin lesions and anti-Sm antibody.
    European journal of dermatology : EJD, 2017, 12-01, Volume: 27, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Gemcitabine; Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Oxonic Acid; Pancreatic Neoplasms; Pyridines; Renal Insufficiency; Tegafur

2017
Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
    JAMA dermatology, 2013, Volume: 149, Issue:9

    Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Eruptions; Female; Gemcitabine; Humans; Lupus Erythematosus, Cutaneous

2013
Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
    The Journal of dermatology, 2013, Volume: 40, Issue:11

    Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Stomach Neoplasms

2013
[Capecitabine-induced subacute cutaneous lupus: a case report].
    Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:10

    Topics: Adverse Drug Reaction Reporting Systems; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnosis, Differential; Female; Fluorouracil; France; Humans; Lupus Erythematosus, Cutaneous; Middle Aged

2014
Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report.
    Chemotherapy, 2016, Volume: 61, Issue:5

    Topics: Administration, Oral; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lupus Erythematosus, Cutaneous; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Skin; Treatment Outcome

2016
Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
    Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:2 Suppl 1

    Topics: Acute Disease; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fatal Outcome; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Severity of Illness Index; Steroids; Stomach Neoplasms

2008
Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Archives of dermatology, 2009, Volume: 145, Issue:3

    Topics: Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous; Middle Aged

2009
Subacute cutaneous lupus erythematosus induced by capecitabine.
    Clinical and experimental dermatology, 2009, Volume: 34, Issue:7

    Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Eruptions; Facial Dermatoses; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous

2009
Subacute cutaneous lupus erythematosus after treatment with capecitabine.
    The Journal of dermatology, 2013, Volume: 40, Issue:1

    Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous

2013
Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes.
    The Lancet. Oncology, 2006, Volume: 7, Issue:8

    Topics: Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Capecitabine; Cyclophosphamide; Deoxycytidine; Drug Administration Schedule; Fluorouracil; Humans; Liver Neoplasms; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Paraneoplastic Syndromes; Pioglitazone; Prostatic Neoplasms; Thiazolidinediones

2006